A Case of Atypical Hemolytic Uremic Syndrome Successfully Treated with Eculizumab

Atypical hemolytic uremic syndrome (aHUS) is a rare thrombotic microangiopathy (TMA) characterized by the triad of hemolytic anemia, thrombocytopenia, and acute renal failure. Eculizumab, a monoclonal complement C5 antibody which prevents the induction of the terminal complement cascade, has recentl...

Descripción completa

Detalles Bibliográficos
Autores principales: Thajudeen, B., Sussman, A., Bracamonte, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2013
Materias:
Published online: December, 2013
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924711/
https://www.ncbi.nlm.nih.gov/pubmed/24570684
http://dx.doi.org/10.1159/000357520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924711/
https://www.ncbi.nlm.nih.gov/pubmed/24570684
http://dx.doi.org/10.1159/000357520

Ejemplares similares